nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

Overview of attention for article published in OncoTargets and therapy, February 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS, 17 Feb 2017

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis https://t.co/jWLV2nqDaR #hvhebron #onco [Te…